An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021040
Company: TEVA WOMENS

Products on NDA 021040

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PREFEST	ESTRADIOL; NORGESTIMATE	1MG,1MG;N/A,0.09MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021040

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/22/1999	ORIG-1	Approval	Type 4 - New Combination	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21040LBL.PDF https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/21040LTR.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021040_s000_OrthoPrefestTOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/01/2017	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021040s013lbl.pdf
07/13/2004	SUPPL-12	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21040s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21040s012ltr.pdf
11/13/2002	SUPPL-11	Manufacturing (CMC)		Label is not available on this site.
01/23/2003	SUPPL-10	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr010ltr.pdf
12/19/2003	SUPPL-9	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr001,002,005,007,009ltr.pdf
10/30/2001	SUPPL-8	Labeling		Label is not available on this site.
12/19/2003	SUPPL-7	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr001,002,005,007,009ltr.pdf
01/18/2001	SUPPL-6	Manufacturing (CMC)		Label is not available on this site.
12/19/2003	SUPPL-5	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr001,002,005,007,009ltr.pdf
11/06/2000	SUPPL-3	Manufacturing (CMC)-Expiration Date		Label is not available on this site.
12/19/2003	SUPPL-2	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr001,002,005,007,009ltr.pdf
12/19/2003	SUPPL-1	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21040slr001,002,005,007,009ltr.pdf

Labels for NDA 021040

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/01/2017	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021040s013lbl.pdf
07/13/2004	SUPPL-12	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21040s012lbl.pdf
12/19/2003	SUPPL-9	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf
12/19/2003	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf
12/19/2003	SUPPL-5	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf
12/19/2003	SUPPL-2	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf
12/19/2003	SUPPL-1	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021040s009lbl.pdf
10/22/1999	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21040LBL.PDF

Top